Finance

U.S. prosecutors consider more charges against ex-CEO Shkreli

Posted on

Martin Shkreli, former CEO of Turing Pharmaceuticals LLC, appears before a House Oversight and Government Reform hearing on Capitol Hill in Washington in this file picture taken February 4, 2016. REUTERS/Joshua Roberts/Files Thomson ReutersFile photo of Shkreli, former CEO of Turing Pharmaceuticals LLC, appearing before a hearing in Washington

NEW YORK (Reuters) – Former drug executive Martin Shkreli, who last year became a lightning rod for outrage over soaring prescription drug prices, may face additional U.S. charges of securities fraud, a federal prosecutor said on Tuesday.

More charges related to Shkreli’s involvement with biopharmaceutical company Retrophin Inc could be filed within a month, Assistant U.S. Attorney Winston Paes said at a hearing in federal court in Brooklyn, New York.

(Reporting by David Ingram; Editing by Nick Zieminski)

Read the original article on Reuters. Copyright 2016. Follow Reuters on Twitter.

Related Items:
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Most Popular

65.2K
Automotive

Comment Of The Day: Truth In Bragging Edition
20.0K
Finance

The world’s most popular migrant routes, in maps
Finance

Amazon poached 30 executives from Microsoft in the past 3 years — 6 times as many executives as the next lead poacher, Google (AMZN)
18.3K
Tech

1920+: Alternate history WWI shooter with friggin’ amazing concept art
17.2K
Tech

The Secret Life of Pets trailer: What do a bunny, snake and bulldog have in common?
Sports

Sin City: Knights make awful bet with ‘tout’ site, get roasted, then end partnership quicker than a Vegas marriage
16.1K
Tech

iPhone 6c specs, price and design revealed in huge new leak
15.6K
Tech

Galaxy S7 edge concept design has us craving the real thing
To Top